← Back
$PCRX All transactions

Pacira BioSciences, Inc.

▼ SELL 10b5-1 Plan

$ Value

$83K

Shares

4,000

Price

$21

Filed

Feb 3

Insider

Name

RIKER LAUREN

Title

Senior Vice President, Finance

CIK

0001545439

Roles

Officer

Transaction Details

Transaction Date

2026-02-02

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

52,313

Footnotes

Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award. | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.35 to $21.28, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 3.

Filing Info

Accession No.

0001628280-26-005158

Form Type

4

Issuer CIK

0001396814

RIKER LAUREN's History

Date Ticker Type Value
2026-02-11 PCRX A $0
2026-02-02 PCRX $83K
2026-01-30 PCRX F $57K
2026-01-05 PCRX $34K
2026-01-02 PCRX F $4K
2025-06-04 PCRX $146K
2025-06-03 PCRX F $89K

Other Insiders at PCRX (90d)

Insider Bought Sold Last
WILLIAMS KRISTEN
Chief Administrative Officer
$270K 2026-02-11
RIKER LAUREN
Senior Vice President, Finance
2026-02-11
Cross Shawn
Chief Financial Officer
$303K 2026-04-22
Hirawat Samit 2026-01-27
Lee Frank D.
Chief Executive Officer
2026-02-11
SLONIN JONATHAN
Chief Medical Officer
2026-02-11
Teehan Brendan
Chief Commercial Officer
2026-02-11